According to our results, lnc‐MKRN2‐42:1 expression levels were positively correlated with the severity of dyskinesia and dysarthria but were not correlated with other clinical symptoms, so only the correlation analysis for UPDRS III is presented here. The gene discussed is MKRN2; the disease is Dyskinesia.